Strength Training Effective for Managing Blood Pressure, Study Finds

Health & Lifestyle
496

Translate to Spanish or other 102 languages!

Strength training may be a noninvasive way to manage high blood pressure, a study suggests. Image for illustration purposes
Strength training may be a noninvasive way to manage high blood pressure, a study suggests. Image for illustration purposes

Medical News Today

- Advertisement -
  • High blood pressure or hypertension is a common condition that can lead to serious problems without proper management. 
  • High blood pressure management can involve using medications and lifestyle modifications. 
  • Data from a systematic review and meta-analysis found that strength training may be an effective non-medication option for the management of high blood pressure. However, its effectiveness depends on factors like intensity level and duration.

Follow the link below to read the full story on Medical News Today: https://www.medicalnewstoday.com/articles/hypertension-strength-training-helps-manage-high-blood-pressure?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-04-14&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
No Amount of Alcohol is Safe for Your Heart
Next article
What You NEED to Know About Chagas Disease

More Articles

$281 Million Unlocked to Bridge the Gap in Rural Medical Access

AUSTIN - Governor Greg Abbott announced the Texas Health and Human Services Commission (HHSC) will receive $281 million in federal funding for the second year of Rural Texas Strong, a five-year initiative to improve rural healthcare throughout the state.

Skin Myths Dermatologists Want You to Stop Believing Immediately

Have you ever wondered what a dermatologist's top skincare recommendations are

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.
- Advertisement -